TY - JOUR
T1 - Gut microbiota mediates intermittent-fasting alleviation of diabetes-induced cognitive impairment
AU - Liu, Zhigang
AU - Dai, Xiaoshuang
AU - Zhang, Hongbo
AU - Shi, Renjie
AU - Hui, Yan
AU - Jin, Xin
AU - Zhang, Wentong
AU - Wang, Luanfeng
AU - Wang, Qianxu
AU - Wang, Danna
AU - Wang, Jia
AU - Tan, Xintong
AU - Ren, Bo
AU - Liu, Xiaoning
AU - Zhao, Tong
AU - Wang, Jiamin
AU - Pan, Junru
AU - Yuan, Tian
AU - Chu, Chuanqi
AU - Lan, Lei
AU - Yin, Fei
AU - Cadenas, Enrique
AU - Shi, Lin
AU - Zhao, Shancen
AU - Liu, Xuebo
N1 - Publisher Copyright:
© 2020, The Author(s).
PY - 2020/12/1
Y1 - 2020/12/1
N2 - Cognitive decline is one of the complications of type 2 diabetes (T2D). Intermittent fasting (IF) is a promising dietary intervention for alleviating T2D symptoms, but its protective effect on diabetes-driven cognitive dysfunction remains elusive. Here, we find that a 28-day IF regimen for diabetic mice improves behavioral impairment via a microbiota-metabolites-brain axis: IF enhances mitochondrial biogenesis and energy metabolism gene expression in hippocampus, re-structures the gut microbiota, and improves microbial metabolites that are related to cognitive function. Moreover, strong connections are observed between IF affected genes, microbiota and metabolites, as assessed by integrative modelling. Removing gut microbiota with antibiotics partly abolishes the neuroprotective effects of IF. Administration of 3-indolepropionic acid, serotonin, short chain fatty acids or tauroursodeoxycholic acid shows a similar effect to IF in terms of improving cognitive function. Together, our study purports the microbiota-metabolites-brain axis as a mechanism that can enable therapeutic strategies against metabolism-implicated cognitive pathophysiologies.
AB - Cognitive decline is one of the complications of type 2 diabetes (T2D). Intermittent fasting (IF) is a promising dietary intervention for alleviating T2D symptoms, but its protective effect on diabetes-driven cognitive dysfunction remains elusive. Here, we find that a 28-day IF regimen for diabetic mice improves behavioral impairment via a microbiota-metabolites-brain axis: IF enhances mitochondrial biogenesis and energy metabolism gene expression in hippocampus, re-structures the gut microbiota, and improves microbial metabolites that are related to cognitive function. Moreover, strong connections are observed between IF affected genes, microbiota and metabolites, as assessed by integrative modelling. Removing gut microbiota with antibiotics partly abolishes the neuroprotective effects of IF. Administration of 3-indolepropionic acid, serotonin, short chain fatty acids or tauroursodeoxycholic acid shows a similar effect to IF in terms of improving cognitive function. Together, our study purports the microbiota-metabolites-brain axis as a mechanism that can enable therapeutic strategies against metabolism-implicated cognitive pathophysiologies.
UR - http://www.scopus.com/inward/record.url?scp=85079675480&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079675480&partnerID=8YFLogxK
U2 - 10.1038/s41467-020-14676-4
DO - 10.1038/s41467-020-14676-4
M3 - Article
C2 - 32071312
AN - SCOPUS:85079675480
SN - 2041-1723
VL - 11
JO - Nature communications
JF - Nature communications
IS - 1
M1 - 855
ER -